Topical naphazoline in treatment of myopathic ptosis.
We instilled naphazoline Hcl (0.1%), an imidazole derivative with preferential alpha-2 activity, in 17 eyes of 12 patients with myopathic ptosis due to involvement of the levator palpebrae superioris, in the attempt to selectively stimulate Müller's smooth muscle. Naphazoline significantly widened the palpebral fissure with little change in pupillary diameter and no significant change in ocular pressure, visual acuity and near point determination. However, a reduction of the effect, probably due to tachyphylaxis, was noticed when using naphazoline regularly several times a day for few weeks. In conclusion naphazoline has powerful cosmetical and functional effects in mild to moderate myopathic ptosis above all if taken occasionally.
Institute of Clinical Neurology and Behavioral Sciences, University of Chieti, Italy.
A
A
Uncini
G
G
De Nicola
A
A
Di Muzio
G
G
Rancitelli
L
L
Colangelo
D
D
Gambi
P E
PE
Gallenga
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D001763:Blepharoptosis / Q000188:drug therapy* / Q000503:physiopathology; D005141:Eyelid Diseases / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure; D008297:Male; D008875:Middle Aged; D009278:Naphazoline / Q000008:administration & dosage / Q000627:therapeutic use*; D009801:Oculomotor Muscles / Q000503:physiopathology; D010656:Phenylephrine / Q000627:therapeutic use; D014792:Visual Acuity
D010656:Phenylephrine; D009278:Naphazoline